appearance, residual varicose veins and symptoms

compared with placebo and possible improved QOL
and VCSS. The study concluded that there is a need for
high-quality trials using standardized sclerosant doses,
with well-deﬁned outcome measures and measurement time points to increase the certainty of the evidence. There have been a number of studies that
showed beneﬁt of treatment of recurrent varicosities
after saphenous ablation using either miniphlebectomy or